Back to results
CompletedPhase 1

MAD Study of NX210c

NCT05827653

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Centre for Human Drug Research

Leiden, South Holland, Netherlands

View on ClinicalTrials.gov
MAD Study of NX210c — TrialFind